Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract

Cancer

Volumn 78, Issue 9, 1996, Pages 1881-1887

  Lee, C Soon ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

biliary tract; cell cycle; gallbladder; immunohistochemistry; Ki 67; MIB 1; neoplasm; proliferating cell nuclear antigen

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BILIARY TRACT CANCER; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INVASIVE CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; AMPULLA OF VATER; ANTIGENS, NEOPLASM; ANTIGENS, NUCLEAR; CARCINOMA IN SITU; CELL DIVISION; CHOLECYSTITIS; COMMON BILE DUCT NEOPLASMS; GALLBLADDER NEOPLASMS; HUMANS; KI-67 ANTIGEN; NUCLEAR PROTEINS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0029823615     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961101)78:9<1881::AID-CNCR6>3.0.CO;2-I     Document Type: Article

References (33)

1. Coates M, Day P, McCredie M, Taylor R. Cancer in New South Wales. In: Incidence and Mortality NSW Cancer Council, Sydney, 1992:pp 70-96.
2. Piehler J, Crichlow RW. Primary carcinoma of the gallbladder. Surg Gynecol Obstet 1978;147:929-42.
3. Tompkins RK, Thomas D, Wile A, Longmire WP Jr. Prognostic factors in bile duct carcinoma. Analysis of 96 cases. Ann Surg 1981;194:447-57.
4. Wise L, Pizzimbono C, Dehner LP. Periampullary cancer. A clinicopathologic study of sixty-two patients. Am J Surg 1976;131:141-8.
5. Skalova A, Lehtonen H, von Boguslawsky K, Leivo I. Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol 1994; 25:929-35.
6. Meyer JS. Cell kinetic measurements in human tumors. Hum Pathol 1982;13:874-7.
7. Kamel OW, LeBrun DP, Davis RE, Berry GJ, Wamke RA. Growth fraction estimation of malignant lymphomas in for-malin-fixed paraffin-embedded tissue using anti-PCNA/ cyclin 19A2. Correlation with Ki-67 labelling. Am J Pathol 1991;138:1471-77.
8. Hall PA, Levison DA. Review: assessment of cell proliferation in histological material. J Clin Pathol 1990;43:184-92.
9. Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti PCNA/Cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol 1989;134(4):733-9.
10. Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin section: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-94.
11. McCormick D, Chong H, Hobbs C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 1993;22:355-60.
12. Shivji MJK, Kenny MK, Wood RD. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 1992; 69:367-74.
13. Leonardi E, Girlando S, Serio G, Mauri FA, Perrone G, Scampini S, et al. PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol 1992;45:416-9.
14. Jain S, Filipe MI, Hall PA, Wassem N, Lane DP, Levison DA. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 1991;44:655-9.
15. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31:3-20.
16. Gerdes J, Li L, Schlüter C, Duchrow M, Wohlenberg C, Gerlach C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody KI-67. Am J Pathol 1991;138:867-73.
17. Gerdes J, Lemke H, Baisch H, Wacher H-H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-15.
18. Hall PA, Woods AL. Immunohistochemical markers of cellular proliferation:achievements, problems and prospects. Cell Tissue Kinet 1990;23:505-22.
19. Cattoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
20. Fairman MP. DNA polymerase-delta/PCNA:actions and interactions. J Cell Sci 1990;94:1-4.
21. McCormick D, Hall PA. The complexities of proliferating cell nuclear antigen. Histopathology 1992;21:591-4.
22. Yu C, Hall PA, Fletcher CD, Camplejohn R, Waseem N, Lane DP, et al. Immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen may be a good indicator of prognosis in haemangiopericytomas. J Pathol 1990;161:342A.
23. Hall PA, Richards MA, Gregory WM, d'Ardenne AJ, Lister TA, Stansfeld AG. The prognostic value of Ki 67 immunostaining on non-Hodgkin's lymphoma. J Pathol 1988;154:223-35.
24. 2 + M phase fraction (flow cytometric analysis) and prognosis. Histopathology 1991;19:21-27.
25. Thomas H, Nasim MM, Sarraf CE, Alison MR, Love S, Lambert HE, et al. Proliferating cell nuclear antigen (PCNA) immunostaining - a prognostic factor in ovarian cancer? Br J Cancer 1995;71:357-62.
26. Oya M, Yao T, Nagai E, Tsuneyoshi M. Metastasizing intramucosal gastric carcinomas. Well differentiated type and proliferative activity using proliferative cell nuclear antigen and Ki-67. Cancer 1995;75:926-35.
27. D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG, Grigioni WF. Augmentation of type IV collagenase, laminin receptor, and Ki-67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol 1991;4:239-46.
28. Dervan PA, Magee HM, Buckley C, Carney N. Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlates with Ki-67 in fresh tissue. Am J Clin Pathol 1992;97(Suppl. 1):S21-S28.
29. Leong AS-Y, Milios J, Tang SK. Is immunolocalisation of proliferating cell nuclear antigen (PCNA) in paraffin sections a valid index of cell proliferation? Appl Immunohistochem 1993;1(2):127-35.
30. Lee CS, Redshaw A, Boag G. Assessment of cell proliferation in human laryngeal cancers using proliferating cell nuclear antigen (PCNA) and Ki-67 antigen immunostaining. Cell Vision: J Anal Morphol 1995;2:296-300.
31. Wynford-Thomas D. Oncogenes and anti-oncogenes: the molecular basis of tumour behaviour. J Pathol 1991;165:187-201.
32. Jaskulski D, Gatti G, Travalli S, Calabretta B, Baserga R. Regulation of the proliferating cell nuclear antigen cyclin and thymidine linase mRNA levels by growth factors. J Biol Chem 1984;263:10175-9.
33. Bravo R, MacDonald-Bravo H. Induction of the nuclear protein cyclin in quiescent mouse 3T3 cells stimulated by serum and growth factors. Correlation with DNA synthesis. EMBO J 1984;3:3177-81.